Searched for
TRIAL DATA
Covaxin phase 3 trial data approved by subject expert committee, shows 77.8 % efficacy22 Jun, 2021, 03.30 PM IST
COVID vaccine approval row: Bharat Biotech defends Covaxin after backlash over lack of data04 Jan, 2021, 06.51 PM IST
Covishield row: AstraZeneca reaffirms vaccine safety amidst rare 'side effect' concerns01 May, 2024, 07.24 PM IST
Saurabh Bharadwaj criticises centre for Covishield continuation amid global AstraZeneca withdrawal08 May, 2024, 08.49 PM IST
Covaxin for kids: Bharat Biotech completes phase 2/3 trials of vaccine, to submit data to DCGI next week21 Sep, 2021, 03.04 PM IST
COVID-19 vaccine is over 90% effective: Pfizer, BioNTech say after early data of phase 3 trials09 Nov, 2020, 06.36 PM IST